Mission
The John Paul II Medical Research Institute focuses on the ethical and cost-effective conduct of medical research to develop therapies and cures for various diseases. The Institute emphasizes the dignity of every human life and does not support embryonic stem cell research, instead prioritizing adult stem cell research.
Basic Information
Tax-Exempt
Founded in
2006
EIN
20-5239366
Total Assets
$509.2 thousand
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 3 of 3 goals
At a Glance
COVID-19 Vaccine Research
Engaged in developing vaccines and therapies against COVID-19 using ethical research practices.
Stem Cell Education
Provides educational outreach about the potential of adult stem cells.
Annual Reports
Documents the financial and research progress of the institute over the years.
Impact Stats
$1,000,000
Financial Goal
Campaign for Cures Fundraising Goal for 2024
Aiming to raise $1,000,000 for COVID-19 vaccine and therapies research.
3
Milestones Achieved
2023 Scientific Milestones
Achievement in respiratory virus vaccine research and advancement in stem cell therapy technologies.
Impact Reports
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
42
28
/100
Program Expense Ratio
51.44%
4
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.3318
12
/20
Working Capital Ratio
0.6545
8
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 464.4K | 98.87% |
| Program Services | 4.953K | 1.05% |
| Investment Income | 358 | 0.08% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 469.7K | 100.00% |